OXYCODONE HCl CR TABLETS 10 mg 100s CII
NDC: 00591-3501-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

OXYCODONE HCl CR TABLETS 20 mg 100s CII
NDC: 00591-3502-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

OXYCODONE HCl CR TABLETS 40 mg 100s CII
NDC: 00591-3503-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

OXYCODONE HCl CR TABLETS 80 mg 100s CII
NDC: 00591-3504-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

Oxycodone HCl Controlled-Release Tablets are a controlled-release oral formulation of oxycodone

hydrochloride indicated for the management of moderate to severe pain when a continuous,

around-the-clock analgesic is needed for an extended period of time.

Oxycodone HCl Controlled-Release Tablets are NOT intended for use as a prn analgesic.

Physicians should individualize treatment in every case, initiating therapy at the appropriate point

along a progression from non-opioid analgesics, such as non-steroidal anti-inflammatory drugs

and acetaminophen to opioids in a plan of pain management such as outlined by the World Health

Organization, the Agency for Healthcare Research and Quality (formerly known as the Agency for

Health Care Policy and Research), the Federation of State Medical Boards Model Guidelines, or

the American Pain Society.

Oxycodone HCl Controlled-Release Tablets are not indicated for pain in the immediate postoperative

period (the first 12-24 hours following surgery), or if the pain is mild, or not expected to persist

for an extended period of time. Oxycodone HCl Controlled-Release Tablets are only indicated

for postoperative use if the patient is already receiving the drug prior to surgery or if the postoperative

pain is expected to be moderate to severe and persist for an extended period of time. Physicians

should individualize treatment, moving from parenteral to oral analgesics as appropriate. (See

American Pain Society guidelines.)